articles This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Article 6 months ago - 4 mins read “It Always Seems Impossible Until It’s Done” with Dr. Romyr Dominique Contrary to popular belief, pharma is incredibly competitive, with dozens of companies often working on the same hot target at the same time. What sets pharma apart from the outside world though, is how deeply we respect our competitors and other scientists when they succeed at cracking technical challenges. Here, Dr.… Article 6 months ago - 17 mins read 2021 First-in-Class Small Molecule Drugs together with Dr. Naveed Yasin, Dr. Jennifer Huen, Dr. Vinicius Texeira, and Dr. Adrian Parodi In 2021 there were: 50 novel drugs approved by the FDA 27 that CDER considers first-in-class (FIC) 16 first-in-class small molecules (according to CDER) These drugs are the first in their therapeutic class to have a particular mechanism of action.… Article 6 months ago - 6 mins read FDA Novel Drug Approvals – Jan. 2022 together with Dr. Naveed Yasin, Dr. Jen Huen, and Dr. Adrian Parodi There were four novel drugs approved by the FDA in January 2022 (2 small molecules, 2 large molecules). The novel January 2022 new drug approvals appear below in this Drug Hunter minireview: Novel small molecule FDA drug approvals of January 2022: Quviviq (daridorexant):… Article 6 months ago - 20 mins read 2021 Large Molecule Drug Approvals Review – Pt. 2 together with Jen Huen, Naveed Yasin, Becca Burnham, Arathi Chintireddy, and Adrian Parodi This deep dive into 2021’s novel large molecule drug approvals is the 2nd in a series of focus articles on 2021’s novel large molecule drugs. See part one here. For each of the 16 large molecule drug approvals of 2021 (excluding vaccines),… Article 7 months ago - 9 mins read What is a Drug Hunter? If you’re here reading about drug discovery for fun, you’re probably a drug hunter. You might be someone on your way to a leadership role in pharma or biotech. Maybe you’re decades into your career and already leading an R&D division. You don’t have a PhD in drug hunting, and it’s unlikely to be in… Article 7 months ago - 2 mins read It Takes a Village with Joachim Rudolph New drugs are discovered by teams, not individuals. “Drug discovery is a complex undertaking, and I enjoy the collaboration with many people from different disciplines and expertise areas that it takes to solve this impossible puzzle,” says reviewer Joachim Rudolph. Drug Hunter also takes a community to build, and we want to celebrate… Pages: 1234567891011121314Load More
